Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (168)

11

Clinical implications of the PORTEC-3 trial for the treatment of high-risk endometrial cancer

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2020

von Waltar, T. | Marnitz, S.

12

Adjuvant chemotherapy with Capecitabine as new standard for resected cholangiocarcinomas - a look at the BILCAP trial

enthalten in: Zeitschrift fur Gastroenterologie | 2018

von Liotta, L. | Quante, M.

13

Radiochemotherapy improves failure-free survival in stage III endometrial cancer : Final results of the PORTEC-3 trial

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2017

von Krug, D. | Arians, N.

14

enthalten in: Aktuelle Urologie | 2017

von Rexer, H. | Graefen, M. | Grimm, M.

15

Janus kinase inhibitor baricitinib for rheumatoid arthritis : Randomized, double-blind, placebo- and active-controlled, phase 3 study evaluating the efficacy and safety of baricitinib in patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate therapy (RA-BEAM)

enthalten in: Der Internist | 2017

von Alten, R. | Nitschmann, S.

16

First line therapy for locally advanced or metastatic urothelial cancer : A randomized double blind phase III multicenter study on adjuvant nivolumab therapy versus placebo in patients with invasive high-risk urothelial cancer (CheckMate 274)-AB 58/17 of the AUO

enthalten in: Der Urologe. Ausg. A | 2017

von Rexer, H. | Ohlmann, C. | Gschwend, J. | +1

17

Adjuvant radiotherapy for lymph-node-positive prostate cancer with low tumor load after radical prostatectomy : Multicenter randomized phase III study of the effect of adjuvant radiotherapy in patients with prostate cancer with or without a positive margin after radical prostatectomy (RP) and lymph node metastasis with low tumor load (micrometastases, ≤ 2 lymph node macrometastases). ART-2 - study AP 61/10 of the AUO

enthalten in: Der Urologe. Ausg. A | 2017

von Rexer, H. | Bartkowiak, D.

18

First-line therapy for locally advanced or metastatic urothelial carcinoma : A randomized, controlled phase III trial comparing pembrolizumab with or without platinum-based combination chemotherapy and chemotherapy only in patients with advanced or metastatic urothelial carcinoma (keynote 361-AB 54/16 of the AUO)

enthalten in: Der Urologe. Ausg. A | 2017

von Rexer, H. | Ohlmann, C. | Retz, M.

19

First-line therapy in advanced renal cell carcinoma : A randomized, open-label phase III study evaluating the efficacy and safety of pembrolizumab (MK-3475) in combination with axitinib compared to sunitinib monotherapy as first-line treatment for locally advanced or metastatic renal cell carcinoma (mRCC) (Keynote-426) - AN 39/16 of the AUO

enthalten in: Der Urologe. Ausg. A | 2017

von Rexer, H. | Bedke, J.

20

Inclusion of oxaliplatin in the multimodal treatment of locally advanced rectal cancer

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2017

von Rödel, C. | Fokas, E.